Showing results (341-350 of 3,696) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|November 20, 2024
Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 studyHiroji Iwata, Yoichi Naito, Masaya Hattori, et al.International Journal of Clinical Oncology|November 11, 2024
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resectionMasayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, et al.International Journal of Clinical Oncology|November 13, 2024
Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumorsJin Li, Junli Xue, Tianshu Liu, et al.International Journal of Clinical Oncology|October 14, 2024
Lateral node metastasis in low rectal cancer as a hallmark to predict recurrence patternsEiji Shinto, Hideyuki Ike, Masaaki Ito, et al.International Journal of Clinical Oncology|September 29, 2024
Fourteen-year follow-up results of imatinib therapy in patients with unresectable and metastatic gastrointestinal stromal tumorsTatsuo Kanda, Hiroshi Ichikawa, Takashi Ishikawa, et al.International Journal of Clinical Oncology|September 17, 2024
Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort studyShunsuke Kasai, Hiroyasu Kagawa, Keiichi Hatakeyama, et al.International Journal of Clinical Oncology|September 18, 2024
Pembrolizumab in Japanese patients with primary mediastinal large B-cell lymphoma: results from the KEYNOTE-A33 studyKoji Kato, Sosuke Nakamura, Akira Wakana, et al.International Journal of Clinical Oncology|October 29, 2024
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan ConsortiumTaizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.International Journal of Clinical Oncology|November 6, 2024
Predictive factors of immediate continence after conventional robot-assisted radical prostatectomy: a single-institution retrospective studyYu Ozawa, Shin Koike, Keisuke Aoki, et al.International Journal of Clinical Oncology|October 30, 2024
Efficacy and safety of lenvatinib and pembrolizumab as first-line treatment for advanced renal cell carcinoma patients: real-world experience in JapanTakuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, et al.Pageof 370